Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Receivables - Other: 2019

  • Silence Therapeutics' Receivables - Other was N/A to $34,715 in Q4 2019 from the same period last year, while for Dec 2019 it was $34,715, marking a year-over-year change of. This contributed to the annual value of $34,475 for FY2019, which is N/A change from last year.
  • As of Q4 2019, Silence Therapeutics' Receivables - Other stood at $34,715.
  • Over the past 5 years, Silence Therapeutics' Receivables - Other peaked at $34,715 during Q4 2019, and registered a low of $34,715 during Q4 2019.
  • In the last 1 years, Silence Therapeutics' Receivables - Other had a median value of $34,715 in 2019 and averaged $34,715.